Limula SA

Limula provides a unique automation technology for scalable production of cell therapies. We are based in Lausanne, Switzerland. Our proprietary solution can perform sequential steps of Cell & Gene Therapy (CGT) manufacturing in a single device, using end-to-end automation and integrated process analytics. By combining our expertise and versatile tool, we support the rapid and cost-effective development of cell therapy products across different modalities, at all stages of their life cycle, facilitating the transition from R&D to commercial-scale production.